Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $3,000 | 3 | 55.1% |
| Food and Beverage | $2,137 | 100 | 39.2% |
| Travel and Lodging | $310.93 | 2 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Elite Orthopedics, LLC | $3,026 | 4 | $0 (2018) |
| Paragon 28, Inc. | $579.58 | 5 | $0 (2022) |
| Acera Surgical, Inc. | $419.48 | 28 | $0 (2023) |
| Stryker Corporation | $292.43 | 11 | $0 (2024) |
| Next Science LLC | $269.48 | 17 | $0 (2023) |
| ProgenaCare Global, LLC | $258.36 | 5 | $0 (2023) |
| Organogenesis Inc. | $207.68 | 11 | $0 (2022) |
| Integra LifeSciences Corporation | $63.29 | 5 | $0 (2020) |
| Paratek Pharmaceuticals, Inc. | $53.49 | 3 | $0 (2023) |
| AXOGEN | $45.16 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48.13 | 3 | Stryker Corporation ($17.90) |
| 2023 | $690.48 | 30 | Next Science LLC ($269.48) |
| 2022 | $436.72 | 29 | Acera Surgical, Inc. ($318.07) |
| 2021 | $123.65 | 6 | Acera Surgical, Inc. ($45.86) |
| 2020 | $76.90 | 5 | AXOGEN ($23.45) |
| 2019 | $180.34 | 7 | Organogenesis Inc. ($89.42) |
| 2018 | $2,041 | 18 | Elite Orthopedics, LLC ($1,303) |
| 2017 | $1,851 | 7 | Elite Orthopedics, LLC ($1,723) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/11/2024 | Bioventus LLC | EXOGEN ULTRASOUND BONE HEALING SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: DEVICES | ||||||
| 06/24/2024 | Stryker Corporation | DART-FIRE (Device) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 11/16/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: Surgical Site Infection | ||||||
| 09/21/2023 | Next Science LLC | SURGX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Surgical Site Infection | ||||||
| 08/31/2023 | Next Science LLC | SURGX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $12.95 | General |
| Category: Surgical Site Infection | ||||||
| 08/16/2023 | Next Science LLC | SURGX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $29.20 | General |
| Category: Surgical Site Infection | ||||||
| 08/14/2023 | Stryker Corporation | ORTHOLOC 2 LAPIFUSE (Device) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 06/29/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $20.80 | General |
| Category: Surgical Site Infection | ||||||
| 06/29/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: Surgical Site Infection | ||||||
| 06/15/2023 | TREACE MEDICAL CONCEPTS, INC. | LAPIPLASTY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: FOOT AND ANKLE | ||||||
| 06/15/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $6.88 | General |
| Category: Surgical Site Infection | ||||||
| 06/08/2023 | Stryker Corporation | ORTHOLOC 2 LAPIFUSE (Device) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 05/24/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: ANTIBIOTIC | ||||||
| 05/19/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $14.04 | General |
| Category: Surgical Site Infection | ||||||
| 05/19/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $5.84 | General |
| Category: Surgical Site Infection | ||||||
| 05/19/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $3.66 | General |
| Category: Surgical Site Infection | ||||||
| 04/30/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $16.55 | General |
| Category: Surgical Site Infection | ||||||
| 04/22/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| Category: Surgical Site Infection | ||||||
| 04/22/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $21.12 | General |
| Category: Surgical Site Infection | ||||||
| 04/22/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Surgical Site Infection | ||||||
| 03/24/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $36.67 | General |
| Category: Surgical Site Infection | ||||||
| 03/24/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $8.27 | General |
| Category: Surgical Site Infection | ||||||
| 03/24/2023 | Next Science LLC | SurgX (Device), Xperience, BlastX | Food and Beverage | Cash or cash equivalent | $3.60 | General |
| Category: Surgical Site Infection | ||||||
| 03/23/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: ANTIBIOTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 975 | 1,649 | $201,192 | $74,702 |
| 2022 | 16 | 1,111 | 1,789 | $208,910 | $83,255 |
| 2021 | 18 | 1,362 | 2,296 | $275,296 | $107,262 |
| 2020 | 15 | 1,219 | 1,830 | $211,347 | $73,668 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 125 | 185 | $29,103 | $12,557 | 43.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 116 | 116 | $24,484 | $9,851 | 40.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 135 | 216 | $21,036 | $9,330 | 44.4% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2023 | 60 | 127 | $18,273 | $7,353 | 40.2% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 112 | 228 | $23,256 | $7,173 | 30.8% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2023 | 99 | 202 | $14,948 | $5,011 | 33.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 12 | 45 | $10,379 | $4,595 | 44.3% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2023 | 53 | 83 | $10,300 | $4,381 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 39 | $8,939 | $3,733 | 41.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,430 | $2,599 | 40.4% |
| 11750 | Permanent removal fingernail or toenail | Office | 2023 | 14 | 19 | $9,842 | $2,013 | 20.5% |
| 29540 | Placement of strapping to ankle or foot | Office | 2023 | 62 | 86 | $9,632 | $1,941 | 20.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 29 | 29 | $4,087 | $1,516 | 37.1% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 23 | 29 | $4,176 | $1,202 | 28.8% |
| 11719 | Trimming of fingernails or toenails | Office | 2023 | 48 | 89 | $4,539 | $759.14 | 16.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 36 | 136 | $1,768 | $687.13 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 288 | $38,880 | $18,844 | 48.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 143 | 143 | $29,029 | $11,329 | 39.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 118 | 188 | $15,228 | $7,891 | 51.8% |
| 11056 | Removal of noncancer thickened skin growth, 2-4 growths | Office | 2022 | 73 | 131 | $18,209 | $7,641 | 42.0% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 121 | 220 | $22,440 | $6,848 | 30.5% |
| 11720 | Removal of fingernails or toenails, 1-5 nails | Office | 2022 | 131 | 238 | $17,612 | $5,711 | 32.4% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 19 | 52 | $10,972 | $5,150 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 52 | $10,452 | $4,893 | 46.8% |
| 11055 | Removal of noncancer thickened skin growth, 1 growth | Office | 2022 | 64 | 92 | $10,672 | $4,845 | 45.4% |
About Dr. David Kee, DPM
Dr. David Kee, DPM is a Foot & Ankle Surgery healthcare provider based in Breese, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992772289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kee, DPM has received a total of $5,448 in payments from pharmaceutical and medical device companies, with $48.13 received in 2024. These payments were reported across 105 transactions from 21 companies. The most common payment nature is "Education" ($3,000).
As a Medicare-enrolled provider, Kee has provided services to 4,667 Medicare beneficiaries, totaling 7,564 services with total Medicare billing of $338,886. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Foot & Ankle Surgery
- Other Specialties Foot & Ankle Surgery
- Location Breese, IL
- Active Since 03/05/2006
- Last Updated 12/30/2021
- Taxonomy Code 213ES0103X
- Entity Type Individual
- NPI Number 1992772289
Products in Payments
- Gorilla Plating System (Device) $526.68
- Restrata Wound Matrix (Device) $419.48
- SurgX (Device) $214.97
- Apligraf (Biological) $140.70
- Fixos (Device) $93.07
- ORTHOLOC 2 LAPIFUSE (Device) $73.82
- OMNIGRAFT (Device) $63.29
- SURGX (Device) $54.51
- NUZYRA (Drug) $53.49
- Puraply (Medical Supply) $46.70
- FIXOS (Device) $46.21
- LAPIDUS NAIL (Device) $39.75
- ASNIS (Device) $38.15
- Baxdela (Drug) $28.77
- CoLink (Device) $27.31
- PRIMATRIX (Device) $27.25
- Primatrix (Device) $25.21
- Exogen Ultrasound Bone Healing System (Device) $23.64
- AVANCE NERVE GRAFT (Device) $23.45
- ANCHORAGE (Device) $23.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.